Private company
Cel-Sci Corporation
Cel-Sci Corporation (NYSE American: CVM), is a biotechnology company that tests drugs for the treatment of cancer, autoimmune and infectious diseases through the research and development of immunotherapy products. Cel-Sci's main product is the drug Multikine, an immunotherapeutic agent designed to fight cancer by stimulating the body's immune system.2 It is headquartered in Vienna, United States.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- HeadquartersVienna, United States1
- Legal formFor-Profit Corporation3
- LEI549300FIWOFSETIVMI173
- StatusActive3
- LEI statusLapsed (not renewed)3
- Registered addressc/o C T CORPORATION SYSTEM, 80112 Centennial, United States3
- Registered withBusiness Division of the Secretary of State’s office, 198715135093
See how the biggest companies compare on our leaderboards
Cel-Sci Corporation (NYSE American: CVM), is a biotechnology company that tests drugs for the treatment of cancer, autoimmune and infectious diseases through the research and development of immunotherapy products. Cel-Sci's main product is the drug Multikine, an immunotherapeutic agent designed to fight cancer by stimulating the body's immune system.2
Timeline
- Mar 22, 1983Founded Cel-Sci Corporation is founded3
Links
- WikipediaCel-Sci Corporation
- WikidataQ96418023
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataCel-Sci Corporation on Wikidata
- 2WikipediaCel-Sci Corporation on Wikipedia
- 3